I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Max Kates, M.D.
Max Reuben Kates, M.D.
Co-Director, Bladder Cancer Multidisciplinary Clinic
Assistant Professor of Urology
Expertise: Benign Prostatic Hyperplasia (BPH), Bladder Cancer, Kidney Cancer, Penile Cancer, Prostate Cancer, Robotic Cystectomy, Robotic Nephrectomy, Robotic Partial Nephrectomy, Robotic Prostatectomy, Robotic Surgery, Testicular Cancer ...read more
Request an Appointment
I live in Maryland
Request an appointment through My
I live outside of Maryland
I live outside of the United States
Dr. Max Kates is an Assistant Professor of Urology and Oncology in the Brady Urological Institute. Dr. Kates received his undergraduate degree from Wesleyan University in Connecticut, and his medical degree from Mount Sinai School of Medicine in New York. During that time he completed a Doris Duke clinical research fellowship in Urologic Oncology at Columbia University, College of Physicians and Surgeons.
Dr. Kates has expertise in all areas of urologic oncology, including prostate, bladder, kidney, testicular, and genital cancers. With training in open, laparoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery.
As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches.
Dr. Kates’ research interest parallel his clinical practice, with an emphasis on novel treatments for cancers of the urinary tract. He has a particular interest in developing novel therapies for bladder cancer, and currently has a provisional patent for a novel intravesical chemotherapy he developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer.
Dr. Kates has authored more than 70 journal articles in the fields of bladder, prostate, and kidney cancer. He has won numerous awards, including the American Urologic Association (AUA) Russell Scott Award, best poster awards from the society of urologic oncology and AUA, and best reviewer from the journal Urologic Oncology.
To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009.
- Co-Director, Bladder Cancer Multidisciplinary Clinic
- Assistant Professor of Urology
- Assistant Professor of Oncology
- MD, Mount Sinai School of Medicine (2012)
- Johns Hopkins University School of Medicine / Urology (2018)
- Pending/Scheduled / Urology